GERON CORPGERNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 9.99% | 63.3M | flat | 2024-11-14 |
| BlackRock, Inc. | 7.80% | 42.2M | — | 2024-01-26 |
| RTW Investments, LP | 7.30% | 44.1M | — | 2024-11-14 |
| The Vanguard Group | 5.26% | 28.6M | — | 2024-02-13 |
| STATE STREET CORPORATION | 4.72% | 374.2M | — | 2024-01-22 |
| Deep Track Capital, LP | 1.26% | 7.6M | ▼ -4.19pp | 2024-11-14 |
Insider Transactions
Net 90d: −$19.1K · buys $0 / sells $19.1KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Spiegel Robert J. | Director | Grant | 5.2K | $1.49 | $7.8K |
| 2026-02-18 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Option exercise | 27.5K | $0.00 | $0 |
| 2026-02-18 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell (open market) | 9.9K | $1.94 | $19.1K |
1–3 of 3